Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells
β Scribed by Dr. Manabu Sotomatsu; Shin-Ichirou Yugami; Toshiji Shitara; Takayoshi Kuroume
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 410 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
of a de novo Ph in T-cell acute leukemia. So this case could be the first de novo T-cell childhood ALL showing the expression of p210 protein associated with a very aggressive clinical evolution.
In children with acute lymphoblastic leukemia (ALL), abnormalities in mineral homeostasis and bone mass were first reported by our group in the late 1980s. Prospective longitudinal cohort studies in 40 consecutive patients receiving treatment according to the Dana-Farber Cancer Institute (DFCI) prot
## BACKGROUND. Previously, the authors reported that specific antisense suppression of overexpressed proline-directed protein kinase (PDPK) F A enhances the chemosensitivity of various clinical anticancer drugs up to ΟΎ 100-fold in human prostate carcinoma cells, suggesting an association of PDPK F